These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study. Matsumoto T, Andoh A, Okawa K, Ito H, Torii A, Yoshikawa S, Nakaoka R, Okuyama Y, Oshitani N, Nishishita M, Watanabe K, Fukunaga K, Ohnishi K, Kusaka T, Yokoyama Y, Sasaki M, Tsujikawa T, Aoki T, Kusaka T, Takeda Y, Umehara Y, Nakamura S, Fujiyama Y. Ther Apher Dial; 2008 Dec; 12(6):484-90. PubMed ID: 19140847 [Abstract] [Full Text] [Related]
6. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis. Shimada M, Iwase H, Tsuzuki T, Hirashima N, Kobayashi K, Hibino Y, Watanabe H, Ryuge N, Ando T, Goto H, Yagi Y, Tsujikawa T, Andoh A. Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719 [Abstract] [Full Text] [Related]
7. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S, Adacolumn Study Group. Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921 [Abstract] [Full Text] [Related]
9. A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis. Ashida T, Kohgo Y, Munakata A, Noguchi M, Iizuka B, Endo Y, Hanai H, Yoshikawa T, Matsumoto T, Aoyama N, Matsui T, Mitsuyama K, Hibi T. Transfus Apher Sci; 2011 Apr; 44(2):113-7. PubMed ID: 21402309 [Abstract] [Full Text] [Related]
12. Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis. Fukunaga K, Kamikozuru K, Yokoyama Y, Hida N, Ohda Y, Takeda N, Yoshida K, Iimuro M, Kikuyama R, Kato K, Nagase K, Nakamura S, Miwa H, Matsumoto T. J Clin Apher; 2011 Dec; 26(6):326-31. PubMed ID: 22083887 [Abstract] [Full Text] [Related]
15. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Hanai H, Iida T, Takeuchi K, Watanabe F, Maruyama Y, Andoh A, Tsujikawa T, Fujiyama Y, Mitsuyama K, Sata M, Yamada M, Iwaoka Y, Kanke K, Hiraishi H, Hirayama K, Arai H, Yoshii S, Uchijima M, Nagata T, Koide Y. Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1502-6. PubMed ID: 17101300 [Abstract] [Full Text] [Related]
16. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV. Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784 [Abstract] [Full Text] [Related]
20. Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis. Okuyama Y, Andoh A, Nishishita M, Fukunaga K, Kamikozuru K, Yokoyama Y, Ueno Y, Tanaka S, Kuge H, Yoshikawa S, Sugahara A, Anami E, Munetomo Y, Watanabe C, Fujiyama Y, Matsumoto T. Scand J Gastroenterol; 2013 Apr; 48(4):412-8. PubMed ID: 23356660 [Abstract] [Full Text] [Related] Page: [Next] [New Search]